California Public Employees Retirement System Avrobio, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.84 - $12.6 $497,056 - $798,840	-63,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$10.54 - $19.3 $61,490 - $112,596	-5,834 Reduced 8.43%	63,400 $805,000
Q4 2020 Feb 02, 2021	SELL	$12.79 - $17.1 $16,627 - $22,230	-1,300 Reduced 1.84%	69,234 $965,000
Q3 2020 Nov 05, 2020	BUY	$12.99 - $19.41 $28,578 - $42,702	2,200 Added 3.22%	70,534 $918,000
Q2 2020 Aug 12, 2020	BUY	$12.19 - $22.96 $308,126 - $580,359	25,277 Added 58.71%	68,334 $1.19 Million
Q1 2020 May 12, 2020	BUY	$10.08 - $27.21 $57,456 - $155,097	5,700 Added 15.26%	43,057 $670,000
Q4 2019 Jan 27, 2020	BUY	$13.05 - $21.88 $487,508 - $817,371	37,357 New	37,357 $752,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account